Your browser doesn't support javascript.
loading
An integrated analysis of Sacituzumab govitecan in relapsed or refractory metastatic triple-negative breast cancer.
Cheng, Shao-Xian; Chen, Qiu-Chi; Lin, Guo-He; Han, Yan-Hong; Wang, Bi-Cheng; Dai, Yi; Zhao, Yan-Xia.
Affiliation
  • Cheng SX; Department of General Surgery, Jingshan Union Hospital, Union Hospital, Huazhong University of Science and Technology, Jingshan, China.
  • Chen QC; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Lin GH; Department of Oncology, the Second Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Han YH; Nursing Department, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Wang BC; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Dai Y; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Zhao YX; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Medicine (Baltimore) ; 102(30): e34486, 2023 Jul 28.
Article in En | MEDLINE | ID: mdl-37505137
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoconjugates / Triple Negative Breast Neoplasms Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Medicine (Baltimore) Year: 2023 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoconjugates / Triple Negative Breast Neoplasms Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Medicine (Baltimore) Year: 2023 Type: Article Affiliation country: China